What we're reading, February 2, 2016: Aetna joins other major insurers raising concerns over the Affordable Care Act's insurance exchanges; Sanofi announces plans to develop a Zika vaccine; and Martin Shkreli expected to testify despite dismissing the subpoena.
Aetna has now joined other major insurers who have raised concerns over the sustainability of the Affordable Care Act’s insurance exchanges. The New York Times reported that Aetna has struggled with consumers signing up outside of the open enrollment period. However, CMS recently dropped several special enrollment periods. Aetna is operating in 15 state-based exchanges and has enrolled 750,000 people, but lost more than $100 million on its exchange business in 2015.
As the World Health Organization declared the Zika virus a public health emergency on an international scale, Sanofi announced that it has launched a project to develop a vaccine for the virus, which has been linked to multiple birth defects in Brazil, according to Reuters. Small biotech companies and academic institutions also have plans to develop a vaccine, and GlaxoSmithKline is concluding feasibility studies on its vaccine technology.
Although he dismissed the subpoena, ex-Turing Pharmaceutical CEO Martin Shkreli is expected to appear on Thursday to testify before the House Oversight and Government Committee for the hearing “Developments in the Prescription Drug Market,” reported Roll Call. Other pharmaceutical representatives from Valeant Pharmaceuticals International, Inc, and the Pharmaceutical Care Management Association are expected to testify as well on Thursday.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More